Literature DB >> 6459897

Studies on T cell subsets and functions in leprosy.

M A Bach, L Chatenoud, D Wallach, F Phan Dinh Tuy, F Cottenot.   

Abstract

T cell subsets and T cell functions were explored in 31 leprosy patients with the following methods: determination of the percentages of the different T cell subpopulations defined by monoclonal antibodies directed at total T cells, helper T cells and suppressor/cytotoxic T cells; measurement of the in vitro proliferative responses to mitogens; study of the concanavalin A-induced suppressive activity, assessed on MLC; measurement of delayed-type hypersensitivity by skin testing. The confrontation between immunological lepromatous patients without type-2 reaction (erythema nodosum leprosum), (2) lepromatous patients without ENL (erythema nodosum leprosum), (2) lepromatous patients was recent ENL and (3) tuberculoid patients. Unexpectedly, groups 1 and 3, although differing strongly in their clinical status and their sensitivity to lepromin (absent in group 1 and strong in group 3), showed a similar immunological profile with a normal percentage of T cells and a normal distribution of T cells among the major T cell subset contrasting with a moderate decrease of proliferative responses to mitogens and impaired delayed-type hypersensitivity reactions. Concanavalin A-induced suppressive activity was type-2 reaction) strongly differed from both other groups, showing striking abnormalities other groups, showing striking abnormalities of the repartition of the T cell subsets, with increased percentages of helper T cells and decreased percentages of suppressor T cells, and elevated proliferative responses to mitogens. Concanavalin A-induced suppressive activity was reduced in most patients of this group. It is suggested that this imbalance between T cell subsets contributes to the occurrence of ENL reactions in lepromatous patients.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6459897      PMCID: PMC1537313     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  31 in total

1.  Impaired delayed hypersensitivity in patients with lepromatous leprosy.

Authors:  D S Waldorf; J N Sheagren; J R Trautman; J B Block
Journal:  Lancet       Date:  1966-10-08       Impact factor: 79.321

2.  Erythema nodosum leprosum: a clinical manifestation of the arthus phenomenon.

Authors:  S N Wemambu; J L Turk; M F Waters; R J Rees
Journal:  Lancet       Date:  1969-11-01       Impact factor: 79.321

3.  Presence of C1q-reactive immune complexes in patients with leprosy.

Authors:  O Rojas-Espinosa; I Mendez-Navarrete; S Estrada-Parra
Journal:  Clin Exp Immunol       Date:  1972-10       Impact factor: 4.330

4.  Prolonged survival of skin allografts in leprosy patients.

Authors:  S H Han; R S Weiser; S T Kau
Journal:  Int J Lepr Other Mycobact Dis       Date:  1971 Jan-Mar

5.  A logarithmic index of bacilli in biopsies. I. Method.

Authors:  D S Ridley; G R Hilson
Journal:  Int J Lepr Other Mycobact Dis       Date:  1967 Apr-Jun

6.  IgG on lymphocyte surfaces; technical problems and the significance of a third cell population.

Authors:  R J Winchester; S M Fu; T Hoffman; H G Kunkel
Journal:  J Immunol       Date:  1975-04       Impact factor: 5.422

7.  Studies of immune mechanisms in leprosy. 3. The role of cellular and humoral factors in impairment of the in vitro immune response.

Authors:  W E Bullock; P Fasal
Journal:  J Immunol       Date:  1971-04       Impact factor: 5.422

Review 8.  Immunological phenomena in leprosy and related diseases.

Authors:  J L Turk; A D Bryceson
Journal:  Adv Immunol       Date:  1971       Impact factor: 3.543

9.  Leprosy XII. Quantitative analysis of thymus-derived lymphocyte response to phytohemagglutinin in leprosy.

Authors:  S D Lim; R R Jacobson; B H Park; R A Good
Journal:  Int J Lepr Other Mycobact Dis       Date:  1975 Apr-Jun

10.  Classification of leprosy according to immunity. A five-group system.

Authors:  D S Ridley; W H Jopling
Journal:  Int J Lepr Other Mycobact Dis       Date:  1966 Jul-Sep
View more
  17 in total

1.  Strain differences in mouse cellular responses to Mycobacterium lepraemurium and BCG subcutaneous infections. I. Analysis of cell surface phenotype in local granulomas.

Authors:  F Roch; M A Bach
Journal:  Clin Exp Immunol       Date:  1990-06       Impact factor: 4.330

2.  In situ characterization of T lymphocyte subsets in the reactional states of leprosy.

Authors:  R L Modlin; J F Gebhard; C R Taylor; T H Rea
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330

Review 3.  The use of monoclonal anti-T cell antibodies to study T cell imbalances in human diseases.

Authors:  M A Bach; J F Bach
Journal:  Clin Exp Immunol       Date:  1981-09       Impact factor: 4.330

4.  [Immune status of patients with bronchial cancer].

Authors:  P Aulenbacher; H G Manke; P Drings
Journal:  Klin Wochenschr       Date:  1987-05-15

5.  Thymus-dependent lymphocytes in leprosy. II. Effect of chemotherapy on T-lymphocyte subpopulations.

Authors:  R N Mshana; A Haregewoin; A Belehu
Journal:  J Clin Immunol       Date:  1982-04       Impact factor: 8.317

6.  Treponemal infection specifically enhances node T-cell regulation of macrophage activity.

Authors:  D R Tabor; O Bagasra; R F Jacobs
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

Review 7.  Suppressor cell activity and phenotypes in the blood or tissues of patients with leprosy.

Authors:  T H Rea
Journal:  Clin Exp Immunol       Date:  1983-11       Impact factor: 4.330

8.  Cyclophosphamide-sensitive activity of suppressor T cells during treponemal infection.

Authors:  D R Tabor; D P Kiel; R F Jacobs
Journal:  Immunology       Date:  1987-09       Impact factor: 7.397

9.  Immunohistological studies of skin biopsies from patients with lepromatous leprosy.

Authors:  R N Mshana; D P Humber; A Belehu; M Harboe
Journal:  J Clin Immunol       Date:  1983-01       Impact factor: 8.317

10.  In vitro proliferative response to M. leprae and PPD of isolated T cell subsets from leprosy patients.

Authors:  M A Bach; D Wallach; B Flageul; F Cottenot
Journal:  Clin Exp Immunol       Date:  1983-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.